AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead.
Source: https://www.fool.com/investing/2026/02/19/3-stocks-to-buy-an…
Stocks like SFD, CHRD, E and OXY are seeing price strength and have a high chance of carrying the momentum forward.
Netflix’s latest move reveals substantial opportunities to deliver returns to shareholders. Microsoft’s cloud growth indicates a strengthening competitive position as AI demand grows.
Investors are uncertain about tech companies because of AI spending, not the Iran war. Four major hyperscalers spent $410.2 billion last year, and there’s concern about whether the returns will justify that kind of investment.
